Literature DB >> 2267136

Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression.

W Deppert1, G Buschhausen-Denker, T Patschinsky, K Steinmeyer.   

Abstract

To further characterize the role of p53 in growing normal Balb/c 3T3 fibroblasts, as well as of p53 in cells of the methylcholanthrene induced fibrosarcoma cell line Meth A, we analysed the effect of inhibition of p53 synthesis by microinjection of p53-specific monoclonal antibody PAb 122 into the nuclei of these cells after release from growth arrest induced by isoleucine starvation (see preceding paper [Steinmeyer et al., this issue] ). We show that microinjection of PAb 122, but not of control immunoglobulins, into the nuclei of both types of cells effectively blocked their re-entry into the S-phase of the cell cycle. Since isoleucine depletion of these cells was shown to lead to a growth arrest at the restriction point (R-point) in the G1-phase of the cell cycle, our results (i) define more precisely the role of p53 in growing cells as a protein controlling transition of the cells through this restriction point, and (ii) demonstrate that mutated p53 in Meth A cells still is functional with regard to cell cycle control at this restriction point. We suggest that p53 acts as a 'gate-keeping' protein at restriction points in the cell cycle, exerting a positive effect on the transition of cells through the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2267136

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  p53 expression in lymphatic malignancies.

Authors:  Y Soini; P Pääkkö; M Alavaikko; K Vähäkangas
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

2.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

3.  Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing.

Authors:  K Will; G Warnecke; L Wiesmüller; W Deppert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

4.  After portal branch ligation in the rat, cellular proliferation is associated with selective induction of c-Ha-ras, p53, cyclin E, and Cdk2.

Authors:  P Stärkel; L Lambotte; C Sempoux; C De Saeger; A Saliez; D Maiter; Y Horsmans
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

5.  Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.

Authors:  O Foord; N Navot; V Rotter
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation.

Authors:  S J van den Heuvel; T van Laar; I The; A J van der Eb
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Low p53 protein expression in salivary gland tumours compared with lung carcinomas.

Authors:  Y Soini; D Kamel; K Nuorva; D P Lane; K Vähäkangas; P Pääkkö
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.

Authors:  S P Lees-Miller; K Sakaguchi; S J Ullrich; E Appella; C W Anderson
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences.

Authors:  F Tiemann; W Deppert
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.